Source: MarketScreener

Alabama Oncology: Alabama Oncology Adopts Deep Lens' VIPER to Expand Clinical Trial Offering to Patient Community

(marketscreener.com) Deep Lens and Alabama Oncology today announced that they have entered into a partnership that will integrate Deep Lens' artificial-intelligence -based clinical trial matching solution, VIPER , into all offices within the Alabama Oncology network. VIPER uses proprietary cloud-based technology to facilitate, triage and accelerate the...https://www.marketscreener.com/news/latest/Alabama-Oncology-Adopts-Deep-Lens-VIPER-trade-to-Expand-Clinical-Trial-Offering-to-Patient-Communi--33038574/?utm_medium=RSS&utm_content=20210422

Read full article »
Est. Annual Revenue
<$1M
Agree?
Est. Employees
<10
Agree?
CEO Avatar

CEO

Update CEO

CEO Approval Rating

- -/100



Alabama Oncology is a Private company. Alabama Oncology has an estimated revenue of <$1M and an estimate of less <10 employees.